C362H226N46O8 — CID 158501725
2,5-bis(9-phenylcarbazol-4-yl)-1,3,4-oxadiazole;2,5-bis[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis(9-pyridin-3-ylcarbazol-4-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-3-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole (PubChem CID 158501725) has the molecular formula C362H226N46O8 and a molecular weight of 5348.10 g/mol. Its IUPAC name is 2,5-bis(9-phenylcarbazol-4-yl)-1,3,4-oxadiazole;2,5-bis[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis(9-pyridin-3-ylcarbazol-4-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-3-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole.
| Compound Name | 2,5-bis(9-phenylcarbazol-4-yl)-1,3,4-oxadiazole;2,5-bis[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis(9-pyridin-3-ylcarbazol-4-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-3-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole |
|---|---|
| PubChem CID | 158501725 |
| Molecular Formula | C362H226N46O8 |
| Molecular Weight | 5348.10 g/mol |
| Exact Mass | 5343.87 |
| IUPAC Name | 2,5-bis(9-phenylcarbazol-4-yl)-1,3,4-oxadiazole;2,5-bis[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2,5-bis(9-pyridin-3-ylcarbazol-4-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenylpyrimidin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-(4,6-diphenyl-1,3,5-triazin-2-yl)carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-[9-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-4-yl]-5-(9-phenylcarbazol-3-yl)-1,3,4-oxadiazole;2-(9-phenylcarbazol-3-yl)-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole |
| SMILES | c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c(-c5nnc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)o5)cccc43)n2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c6c6ccccc6n7-c6cccc(-c7ccccc7)c6)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c6c6ccccc6n7-c6cccc(-c7ccccc7)n6)o5)cccc43)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5c(-c6nnc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)o6)cccc54)c3)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c(-c5nnc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)o5)cccc43)n2)cc1.c1ccc(-n2c3ccccc3c3c(-c4nnc(-c5cccc6c5c5ccccc5n6-c5ccccc5)o4)cccc32)cc1.c1ccc(-n2c3ccccc3c3cc(-c4nnc(-c5cccc6c5c5ccccc5n6-c5cccc(-c6cccnc6)n5)o4)ccc32)cc1.c1cncc(-n2c3ccccc3c3c(-c4nnc(-c5cccc6c5c5ccccc5n6-c5cccnc5)o4)cccc32)c1 |
| InChI | InChI=1S/C53H33N7O.C50H32N4O.2C48H30N6O.C47H29N7O.C42H26N6O.C38H24N4O.C36H22N6O/c1-4-16-34(17-5-1)49-54-50(35-18-6-2-7-19-35)56-51(55-49)36-20-14-23-39(32-36)60-45-28-13-11-25-41(45)48-42(26-15-29-47(48)60)53-58-57-52(61-53)37-30-31-46-43(33-37)40-24-10-12-27-44(40)59(46)38-21-8-3-9-22-38;1-3-15-33(16-4-1)35-19-11-21-37(31-35)53-43-27-9-7-23-39(43)47-41(25-13-29-45(47)53)49-51-52-50(55-49)42-26-14-30-46-48(42)40-24-8-10-28-44(40)54(46)38-22-12-20-36(32-38)34-17-5-2-6-18-34;1-4-15-31(16-5-1)39-30-40(32-17-6-2-7-18-32)50-48(49-39)54-42-25-13-11-22-36(42)45-37(23-14-26-44(45)54)47-52-51-46(55-47)33-27-28-43-38(29-33)35-21-10-12-24-41(35)53(43)34-19-8-3-9-20-34;1-3-15-31(16-4-1)37-23-13-29-43(49-37)53-39-25-9-7-19-33(39)45-35(21-11-27-41(45)53)47-51-52-48(55-47)36-22-12-28-42-46(36)34-20-8-10-26-40(34)54(42)44-30-14-24-38(50-44)32-17-5-2-6-18-32;1-4-15-30(16-5-1)43-48-44(31-17-6-2-7-18-31)50-47(49-43)54-39-25-13-11-22-35(39)42-36(23-14-26-41(42)54)46-52-51-45(55-46)32-27-28-40-37(29-32)34-21-10-12-24-38(34)53(40)33-19-8-3-9-20-33;1-2-12-29(13-3-1)47-35-18-6-4-14-30(35)33-25-27(22-23-37(33)47)41-45-46-42(49-41)32-16-8-20-38-40(32)31-15-5-7-19-36(31)48(38)39-21-9-17-34(44-39)28-11-10-24-43-26-28;1-3-13-25(14-4-1)41-31-21-9-7-17-27(31)35-29(19-11-23-33(35)41)37-39-40-38(43-37)30-20-12-24-34-36(30)28-18-8-10-22-32(28)42(34)26-15-5-2-6-16-26;1-3-15-29-25(11-1)33-27(13-5-17-31(33)41(29)23-9-7-19-37-21-23)35-39-40-36(43-35)28-14-6-18-32-34(28)26-12-2-4-16-30(26)42(32)24-10-8-20-38-22-24/h1-33H;1-32H;2*1-30H;1-29H;1-26H;1-24H;1-22H |
| InChIKey | HJYYAOYPVDVTQA-UHFFFAOYSA-N |
| XLogP | 88.32 |
| TPSA | 570.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 54 |
| Rotatable Bonds | 44 |
| Heavy Atoms | 416 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5348.10 |
| LogP ≤ 5 | 88.32 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 54 |